FDA Endorses Cancer-Screening Blood Test
See how ABC are framing this — we run every side, so you decide. News for humans, not bots: serious, civil discussion among real people, with the context and facts you need. Don't just watch: be on the air with your own video takes, polls and predictions.
EVERY NETWORK'S FRAMING
Watch the moment
Add your voice
The FDA cannot approve a cancer screening test without convening an advisory panel.
The multi-cancer blood test market could hit $9 billion by 2030!
The FDA panel's endorsement could accelerate that boom. Leading tests like Grail's Galleri already cost ~$949 out of pocket, and Medicare doesn't yet cover them — leaving a major access gap despite their early-detection promise.
The FDA-cleared Shield blood test costs ~$895 per screening.
Guardant Health's Shield test won Medicare coverage after FDA clearance in 2024 — critical since ~65 million Americans are eligible for colorectal cancer screening, representing a massive potential market.
Topic poll · all networksHow many cancer types can the new FDA-endorsed blood test detect?
- More than 50
- Exactly 10
- Around 25
- Just 3
Guess, then reveal the answer
More than 50